Andrew Goodman is a partner in Goodwin’s Technology + Life Sciences Group and a member of its Public M+A/Corporate Governance practice. His practice focuses on advising clients on  public company mergers and acquisitions, shareholder activism defense and other significant corporate matters. He works with clients in a variety of industries, including technology and life sciences.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Goodman’s recent work includes:

  • Advising public companies and their boards of directors and committees on issues of fiduciary duties and corporate governance particularly in the contexts of change in control transactions and shareholder activism
  • Counseling public company boards of directors and committees on director-election contests, shareholder opposition to M&A transactions, other shareholder activism campaigns, and other contests for corporate control
  • Advising public companies and their directors on  corporate governance and securities law matters
  • Structuring, negotiating and implementing mergers and acquisitions transactions

He has recently represented or is representing:

Public Company Mergers & Acquisitions

  • PAREXEL in its $5 billion sale to Pamplona Capital Management in a "going private" transaction
  • Amplify Snack Brands (the maker of SkinnyPop popcorn) in its $1.6 billion sale to Hershey 
  • Dimension Therapeutics in its proposed sale to RegenxBio and subsequent acceptance of superior proposal from, and $151 million sale to, Ultragenyx 
  • Imprivata in its $544 million sale to Thoma Bravo in a "going private" transaction
  • Opower in its $532 million sale to Oracle
  • Morgan Stanley in its role as financial advisor to Stemcentrx in its $5.8 billion sale to AbbVie
  • Ocata Therapeutics in its $380 million sale to Astellas Pharma
  • Xoom in its $890 million sale to PayPal
  • Millennial Media in its $248 million sale to AOL
  • Paydiant in its sale to PayPal
  • Teva Pharmaceutical Industries in its disposition of certain assets to Ignyta
  • Concert Pharmaceuticals in its disposition of certain assets to Vertex Pharmaceuticals 
  • Zoll Medical in its $2.21 billion sale to Asahi Kasei Corporation
  • Covidien in its $250 million acquisition of Somanetics
  • High Liner Foods in its $230 million acquisition of Icelandic Group’s U.S. and Asia operations
  • Salary.com in its auction and $80 million sale to Kenexa
  • The Princeton Review in its $170 million acquisition of Penn Foster Education Group
  • Candela in its review of strategic alternatives and sale to Syneron Medical
  • Honest Tea in connection with a strategic investment by Coca-Cola
  • Inverness Medical Innovations in its $1.19 billion acquisition of Matria Healthcare
  • Morgan Stanley Real Estate Fund in its $6.5 billion acquisition of Crescent Real Estate Equities
  • Brookfield Properties in its $9.3 billion acquisition of Trizec Properties
  • Beacon Capital Partners in its $4.8 billion sale of private investment funds to Broadway Real Estate Partners

Proxy Contests and Other Shareholder Activism Defense Matters

  • Monotype in its successful defense of a threatened proxy contest by Starboard Value
  • Cedar Realty Trust in the negotiation of a cooperation agreement with Snow Park Capital
  • Cognizant in the negotiation of a cooperation agreement with Elliott Management
  • PAREXEL in its defense of activist campaigns led by Corvex and Starboard Value
  • Wells Fargo Multi-Sector Income Fund in its response to shareholder proposals from, and entry into standstill agreement with, Saba Capital
  • iRobot in its successful proxy contest concerning board representation against Red Mountain Capital
  • CPS Technologies in its successful defense of a threatened proxy contest and "vote against" campaign by the Horton Group
  • Brightcove in its entry into a cooperation agreement with, and subsequent successful defense of a threatened proxy contest by, Tenzing Global
  • Monogram Residential Trust in its entry into a cooperation agreement with Snow Park Capital
  • Relmada Therapeutics in its proxy contest and related litigation against Laidlaw, which sought unsuccessfully to replace a majority of the company’s board
  • Lionbridge in its response to, and entry into a cooperation agreement with, Glen Capital Partners
  • LoJack in its response to, and entry into a cooperation agreement with, Engine Capital
  • Mac-Gray Corporation in its proxy contests against Moab Partners
Professional Activities

Mr. Goodman is a member of the American Bar Association, where he has served on the Mergers & Acquisitions Market Trends Subcommittee and the Private Equity M&A Subcommittee of the Mergers & Acquisitions Committee.

Recognition

Mr. Goodman was selected for inclusion in Chambers USA: America’s Leading Lawyers for Business and The Legal 500 United States.

In The News

MELDUNGEN

ACTUALITÉS

在新闻中

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2002
Tulane University Law School

(cum laude)

B.A., 1999
University of Rochester

(cum laude)

Admissions

Bar

New York
Massachusetts
California
Louisiana
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师